Bourguignon, Lucie http://orcid.org/0000-0001-8049-6461
Lukas, Louis P. http://orcid.org/0000-0001-9307-0945
Guest, James D. http://orcid.org/0000-0003-0931-0286
Geisler, Fred H. http://orcid.org/0000-0002-0899-9045
Noonan, Vanessa http://orcid.org/0000-0003-3226-9218
Curt, Armin http://orcid.org/0000-0003-0136-8467
Brüningk, Sarah C. http://orcid.org/0000-0003-3176-1032
Jutzeler, Catherine R. http://orcid.org/0000-0001-7167-8271
Funding for this research was provided by:
Swiss Federal Institute of Technology Zurich
Article History
Received: 4 July 2023
Accepted: 8 December 2023
First Online: 6 January 2024
Declarations
:
: Approval for this study (secondary analysis) was received by an institutional ethical standards committee on human experimentation at the University of British Columbia. The original Sygen clinical trial [CitationRef removed–CitationRef removed] also received ethical approval, but was conducted before clinical trials were required to be registered (i.e., no clinicaltrial.gov identifier available). All experiments were performed in accordance with relevant guidelines and regulations. Informed consent to participate was obtained from all of the participants as part of the original study.
: Not applicable.
: The authors declare no competing interests.